Cancer patients in the UK are being denied drugs because of unnecessarily exorbitant prices. Patients in the UK have been told “the NHS will not pay for two such drugs because they are not cost-effective and they have been dropped from the list reimbursed by the government’s special cancer drugs fund.” The findings, which will be … Continue reading British patients being denied drugs because of high prices